For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

The Broad Institute, Inc.

USPTO Granted Patents = 450

CIPO Patents = 1

EPO Patents = 153

Trademarks = 14

Forward Citations = 8,471

Loading Chart...

Loading Chart...

813 inventors (with patents filed for the assignee):

Feng Zhang (132 out of 169 patents)

Aviv Regev (49 out of 54 patents)

Omar O Abudayyeh (36 out of 44 patents)

4. Jonathan S Gootenberg (34 out of 41 patents)

5. Edward Holson (31 out of 44 patents)

6. Florence Fevrier Wagner (29 out of 33 patents)

7. Paul Blainey (28 out of 33 patents)

8. Le Cong (23 out of 25 patents)

9. Bernd Zetsche (21 out of 27 patents)

10. Eric Lander (21 out of 36 patents)

11. David R Liu (19 out of 153 patents)

12. Fei Ran (18 out of 18 patents)

13. Michel Weiwer (17 out of 18 patents)

14. Benito Munoz (16 out of 55 patents)

15. Timothy A Lewis (16 out of 21 patents)

Core Competencies:

CRISPR-Cas Systems

Gene Editing

Insulin Secretion Regulation

Immune Checkpoint Targets

RNA-guided Nucleases

Functional Genomics

Kinase Inhibitors

Cell Culture Techniques

Microglial Progenitors

Antiviral Therapy

Cancer Therapeutics

T-cell Receptor Profiling

450 patents: Sort by Forward Citations

1. 12529092 - IN-SITU SPATIAL TRANSCRIPTOMICS (2026-01-20),

2. 12522872 - METHODS OF DIAGNOSING AND TREATING CANCER IN PATIENTS HAVING OR DEVELOPING RESISTANCE TO A FIRST CANCER THERAPY (2026-01-13),

3. 12522863 - Crispr effector system based coronavirus diagnostics (2026-01-13),

4. 12522807 - RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF (2026-01-13),

5. 12509680 - Methods and compositions for prime editing nucleotide sequences (2025-12-30),

6. 12497610 - FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS FOR SATURATING MUTAGENESIS OF NON-CODING ELEMENTS, COMPOSITIONS, METHODS, LIBRARIES AND APPLICATIONS THEREOF (2025-12-16),

7. 12486289 - Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof (2025-12-02),

8. 12486258 - Compounds and methods for regulating insulin secretion (2025-12-02),

9. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),

10. 12473543 - Adenine base editors with reduced off-target effects (2025-11-18),

11. 12473537 - Three-dimensional cell culture, devices, and use thereof (2025-11-18),

12. 12469580 - IN SILICO DISCOVERY OF EFFECTIVE ANTIMICROBIALS (2025-11-11),

13. 12460244 - Inhibitors of RNA-guided nuclease activity and uses thereof (2025-11-04),

14. 12454687 - Functional genomics using CRISPR-Cas systems, compositions, methods, knock out libraries and applications thereof (2025-10-28),

15. 12447213 - Modulation of novel immune checkpoint targets (2025-10-21),

The Broad Institute, Inc. is a non-profit research institute dedicated to transforming medicine by using genomics to drive new strategies for diagnosing, treating, and preventing disease. It is focused on understanding the human genome and its role in biology and disease, and collaborating with others to accelerate the pace of biomedical discovery and its application to human health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

450 Patents

#8 in Cambridge, MA

#61 in Massachusetts

#1,023 in US

#2,057 in the World

Cambridge, MA, United States of America

The Broad Institute, Inc.

Forward Citations = 8,471

813 inventors:

Feng Zhang (132 out of 169 patents)

Aviv Regev (49 out of 54 patents)

Omar O Abudayyeh (36 out of 44 patents)

4. Jonathan S Gootenberg (34 out of 41 patents)

5. Edward Holson (31 out of 44 patents)

Please report any incorrect information to support@idiyas.com

Loading…